Company News
-
Company News
Uni-Bio Science Group Embarks on New Strategy and Launches New Website, Advancing Towards Becoming a Global Leader in Regenerative Medicine24 November,2025
Learn More
-
Company News
Uni-Bio Science Group and Kexing Biopharm Forge Strategic Partnership to Accelerate Global Expansion of Osteoporosis Treatment Bogutai®12 September,2025
Learn More
-
Company News
Announces 2025 Interim Results29 August,2025
Learn More
-
The four-pillar cultivates new growth engines for high-quality development | Uni-Bio Science Group's 2023 Annual Strategy Conference was successfully held The four-pillar cultivates new growth engines for high-quality development | Uni-Bio Science Group's 2023 Annual Strategy Conference was successfully heldCompany News
13 March,2023
-
Join hands together and Build up a head of steam | Uni-Bio Science Group's 2023 Annual Marketing Conference was successfully heldCompany News
01 March,2023
-
Uni-Bio Science's Chairman Won HK Innopreneur Awards – GBA+ AwardCompany News
17 February,2023
-
2022 Interim Results Pinup® and Boshutai® Generated Remarkable Turnover while Achieving Record High Profit Aim to Build a Highly Commercial-Driven and Specialized R&D PlatformCompany News
29 August,2022
-
Marketing application of BOGUTAI® (teriparatide injection) has been officially accepted by the China National Medical Products Administration (NMPA)Company News
28 June,2022
-
Uni-Bio Science Group opens Hong Kong research centre,Future R&D focus in four major businessesCompany News
13 June,2022
-
Uni-Bio Science Group’s BOSHUTAI® (Acarbose Tablets) successfully selected for Henan thirteen provinces alliance procurementCompany News
02 June,2022
